FDA Proposes Amendment to Virus-Serum-Toxin Act Regulations

Summary

The FDA is proposing a rule to require veterinary biologics prepared under a veterinarian-client-patient relationship to be prepared at the same facility used by the veterinarian for their daily practice, in order to prevent unlicensed establishments from violating the Virus-Serum-Toxin Act.